Central Reinsurance Corporation:企業の戦略・SWOT・財務情報

◆英語タイトル:Central Reinsurance Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C11601
◆発行会社(調査会社):MarketLine
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Central Reinsurance Corporation – Strategy, SWOT and Corporate Finance Report
Summary

Central Reinsurance Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Central Reinsurance Corporation (Central Re) is a financial institution focused on underwriting reinsurance products and services. The company offers a range of life and non-life reinsurance products to its customers. Its portfolio of non-life reinsurance products include fire reinsurance, marine and aviation reinsurance, motor reinsurance, engineering reinsurance, residential earthquake reinsurance and casualty reinsurance. The life reinsurance products offered by the company include health reinsurance, personal accident reinsurance and life reinsurance. In addition, the company provides risk management services. Central Re primarily operates in Taiwan and other Asian markets such as China, Japan and South Korea. Central Re is headquartered in Taipei, Taiwan.

Central Re reported gross written premium (GWP) of TWD14,041.7 million in FY2016, representing an annual declineof 1.1%.

Scope

- Detailed information on Central Reinsurance Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Central Reinsurance Corporation in the form of a SWOT analysis
- An in-depth view of the business model of Central Reinsurance Corporation including a breakdown and examination of key business segments
- Intelligence on Central Reinsurance Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Central Reinsurance Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Central Reinsurance Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Central Reinsurance Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Central Reinsurance Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Central Reinsurance Corporation: Company Overview 6
Central Reinsurance Corporation: Overview and Key Facts 6
Central Reinsurance Corporation: Overview 6
Central Reinsurance Corporation: Key Facts 6
Central Reinsurance Corporation: Key Employees 8
Central Reinsurance Corporation: Key Employee Biographies 9
Central Reinsurance Corporation: Major Products and Services 10
Central Reinsurance Corporation: Company History 11
Central Reinsurance Corporation: Management Statement 13
Central Reinsurance Corporation: Key Competitors 14
Central Reinsurance Corporation: Company Analysis 15
Central Reinsurance Corporation: Business Description 15
Central Reinsurance Corporation: SWOT Analysis 16
Central Reinsurance Corporation: SWOT Overview 16
Central Reinsurance Corporation: Strengths 16
Central Reinsurance Corporation: Weaknesses 17
Central Reinsurance Corporation: Opportunities 17
Central Reinsurance Corporation: Threats 18
Appendix 19
Contact Us 19
Methodology 19
About MarketLine 20

List of Tables
Table 1: Central Reinsurance Corporation: Key Facts
Table 2: Central Reinsurance Corporation: Key Employees
Table 3: Central Reinsurance Corporation: Company History
Table 4: Central Reinsurance Corporation: Key Competitors



★海外企業調査レポート[Central Reinsurance Corporation:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pharmathen Pharmaceuticals SA-製薬・医療分野:企業M&A・提携分析
    Summary Pharmathen Pharmaceuticals SA (Pharmathen) is a healthcare products provider that develops and markets generic products. The company’s products include oral antiplatelet agent, bactericidal cephalosporin antibiotic, retinoid, beta1-selective adrenergic receptor blocking agent, and others. It …
  • Johnson Matthey Plc (JMAT):企業の財務・戦略的SWOT分析
    Johnson Matthey Plc (JMAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Eaton Corporation Plc (ETN):電力:M&Aディール及び事業提携情報
    Summary Eaton Corporation Plc (Eaton) is a power management company. It designs, develops, and sells products and services, which help customers manage electrical, hydraulic and mechanical power more reliably, efficiently, safely, and sustainably. Eaton serves customers in the utility, governmental, …
  • Vapo Oy:企業の戦略的SWOT分析
    Vapo Oy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Subex Ltd (SUBEX):企業の財務・戦略的SWOT分析
    Subex Ltd (SUBEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Interpace Diagnostics Group Inc (IDXG)-製薬・医療分野:企業M&A・提携分析
    Summary Interpace Diagnostics Group Inc (Interpace Diagnostics), formerly PDI Inc, is a developer of molecular diagnostics tests. The company offers PancraGen, a DNA based molecular test that aids in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its pathfinder platform; a …
  • Endo International Plc (ENDP):企業の財務・戦略的SWOT分析
    Endo International Plc (ENDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Sumitomo Realty & Development Co., Ltd.:企業の戦略・SWOT・財務情報
    Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Kyowa Exeo Corporation:企業の戦略・SWOT・財務情報
    Kyowa Exeo Corporation - Strategy, SWOT and Corporate Finance Report Summary Kyowa Exeo Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329):企業の財務・戦略的SWOT分析
    Summary Tianjin Zhongxin Pharmaceutical Group Corp Ltd (TZPG) carries out the manufacturing of traditional Chinese medicine, western medicine and health products. The company offers Chinese patent medicines, Chinese medicinal materials, chemical medicines, dietary supplements, pharmaceutical raw mat …
  • Northwest Bancshares Inc:企業の戦略・SWOT・財務情報
    Northwest Bancshares Inc - Strategy, SWOT and Corporate Finance Report Summary Northwest Bancshares Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • MRC Global Inc (MRC)-石油・ガス分野:企業M&A・提携分析
    Summary MRC Global Inc (MRC) is a provider of pipe, valves and fittings. Its product portfolio include carbon steel pipe, carbon steel fittings and flanges, valve automation, stainless and alloy pipe, stainless and alloy fittings and flanges, industrial products, specialty products, oilfield product …
  • Keyera Corp (KEY):石油・ガス:M&Aディール及び事業提携情報
    Summary Keyera Corp (Keyera) is a midstream oil and gas company. The company offers services such as processing, storage, transportation and marketing of oil and natural gas. It owns and operates raw gas gathering pipelines and processing plants, which collect and process raw natural gas, remove was …
  • Fresenius Medical Care AG & Co KGaA (FME):企業の財務・戦略的SWOT分析
    Fresenius Medical Care AG & Co KGaA (FME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Aetna Inc:企業の戦略・SWOT・財務情報
    Aetna Inc - Strategy, SWOT and Corporate Finance Report Summary Aetna Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • ArcDia International Oy Ltd:医療機器:M&Aディール及び事業提携情報
    Summary ArcDia International Oy Ltd (ArcDia International) is a healthcare service provider that offers vitro diagnostic services and develops products for the rapid testing of infectious diseases. The company's products include maripoc test system, an automated system for rapid multianalyte identif …
  • Arab International Bank:企業の戦略・SWOT・財務分析
    Arab International Bank - Strategy, SWOT and Corporate Finance Report Summary Arab International Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Medical Prognosis Institute A/S (MPI):企業の財務・戦略的SWOT分析
    Summary Medical Prognosis Institute A/S (MPI) is a precision medicine provider that offers cancer treatment solutions. The company offers drug response prediction platforms that provide tools for rationalized drug development and personalized medicine. It offers lead compound selection, drug rescue …
  • Senomyx Inc (SNMX):企業の財務・戦略的SWOT分析
    Summary Senomyx Inc (Senomyx) focuses on the discovery, development and commercialization of novel flavor ingredients and natural high intensity sweeteners (HIS) to packaged food, beverage and ingredient supply industries. The company discovers and develops novel flavor ingredients and natural HIS t …
  • Schindler Holding Ltd (SCHP):企業の財務・戦略的SWOT分析
    Schindler Holding Ltd (SCHP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆